首页> 外文期刊>Explore: the journal of science and healing >Potential Efficacy of Allergen Removed Rhus Verniciflua Stokes Extract to Maintain Progression-Free Survival of Patients With Advanced Hepatobiliary Cancer
【24h】

Potential Efficacy of Allergen Removed Rhus Verniciflua Stokes Extract to Maintain Progression-Free Survival of Patients With Advanced Hepatobiliary Cancer

机译:过敏原的潜在疗效除去了Rhus verniciflua Stokes提取物,以维持晚期肝癌患者的无进展生存期

获取原文
获取原文并翻译 | 示例
           

摘要

Hepatobiliary cancers are among the leading causes of cancer-related deaths worldwide. Most of the early-stage, surgically resectable cases show recurrence, and when they do, the prognosis is dismal with limited available treatment options. Here, we report three patients with relapsed hepatobiliary cancers who presented relatively long progression-free survival with the administration of a natural product, allergen removed Rhus vemiciflua Stokes (RVS) extract. After commencement of RVS extract, they were progression-free for over 56 months in one case of recurred cholangiocarcinoma, and for over 16 and 114 months respectively, in two cases of advanced hepatocellular carcinoma. These cases suggest that the extract could be a potential alternative for advanced hepatobiliary cancer that has no other available treatment.
机译:肝胆癌是全世界癌症相关死亡的主要原因。 大多数早期,手术可重置案显示复发,当他们这样做时,预后是有限的可用治疗方案令人沮丧。 在这里,我们报告了三名复发肝癌的患者,随着天然产物的给药,过敏原除去了RHUSVemiflua Stokes(RVS)提取物的过敏原呈现相对较长的进展生存。 在开始RVS提取物后,在两种情况下,它们在两种情况下,在两种情况下进行了56个月,在两种情况下进行了56个月的进展。 这些病例表明,提取物可能是没有其他可用治疗的晚期肝胆癌的潜在替代方案。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号